Moderna announces supply agreement with U.S. government for 100 million doses of mRNA vaccine
CAMBRIDGE: Moderna Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced that the U.S. government has secured 100 million doses of mRNA-1273 as part of the U.S….